CHENGDU, China--(BUSINESS WIRE)--HitGen and Fierce Biotech jointly release the Whitepaper: Advancing Drug Discovery through DNA-Encoded Library (DEL) Technology today. This whitepaper will provide the ...
SHANGHAI and BOSTON, Sept. 3, 2019 /PRNewswire/ -- WuXi AppTec today announced its launch of DELight, a novel DNA Encoded Library (DEL) service package, providing cost-effective and efficient hit ...
COPENHAGEN, Denmark, Feb. 17, 2021 /PRNewswire/ — Vipergen ApS announced today a published study describing a powerful new drug discovery approach that enables, for the first time, screening ...
LONDON--(BUSINESS WIRE)-- Global Healthcare Opportunities, or GHO Capital Partners LLP (GHO), the European specialist investor in healthcare, announces the acquisition of X-Chem, Inc. (X-Chem), the ...
DNA-Encoded Library (DEL) technology has transformed early-stage drug discovery by enabling the simultaneous synthesis and screening of millions to billions of small molecules in a single pooled ...
DNA-encoded library (DEL) technology is a promising new tool for identifying ligands for challenging protein targets, allowing for the preparation and screening of large chemical libraries with ...
(MENAFN- EIN Presswire) EINPresswire/ -- The global DNA encoded library (DEL) market is witnessing strong growth, driven by increasing demand for efficient and scalable drug discovery technologies.
The Scripps Research Institute (TSRI), a leading non-profit biomedical research institute, today announced a research collaboration and license agreement with Pfizer Inc. (NYSE: PFE) to pioneer new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results